1. Home
  2. GRF vs ONMD Comparison

GRF vs ONMD Comparison

Compare GRF & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Capital Growth Fund Inc.

GRF

Eagle Capital Growth Fund Inc.

N/A

Current Price

$10.20

Market Cap

41.0M

Sector

Finance

ML Signal

N/A

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$1.02

Market Cap

45.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRF
ONMD
Founded
1989
2006
Country
United States
United States
Employees
N/A
23
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
41.0M
45.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GRF
ONMD
Price
$10.20
$1.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.9K
832.7K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
3.70%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.50
$0.31
52 Week High
$11.85
$4.22

Technical Indicators

Market Signals
Indicator
GRF
ONMD
Relative Strength Index (RSI) 49.27 54.48
Support Level $9.60 $0.62
Resistance Level $10.61 $1.14
Average True Range (ATR) 0.16 0.12
MACD 0.03 -0.01
Stochastic Oscillator 63.76 36.88

Price Performance

Historical Comparison
GRF
ONMD

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock, giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Share on Social Networks: